Helicobacter pylori is a Gram-negative, microaerophilic bacterium that is commonly found in the stomach. It is found in approximately half of the world’s population (
1). The infection is mostly acquired earlier in life and is common in less developed countries. There is a positive correlation between
H. pylori and peptic ulcers. In some patients, the disease progresses to intestinal metaplasia, dysplasia, and carcinoma (
2).
Helicobacter pylori infection can be diagnosed by different techniques, including invasive techniques, requiring endoscopy and biopsy (e.g., histological examination) and non-invasive techniques, such as serology, urea breath test, urine/blood test, or the detection of
H. pylori antigen in stool specimens (
3).
Stool antigen tests were introduced after the urea breath test. Early stool antigen tests used an Enzyme Immunoassay (EIA) based on polyclonal antibodies. Although this test provides reliable results in the diagnosis of
H. pylori infection, there are some controversial results in the post-eradication assessment because of false-positive results. Stool antigen tests based on monoclonal antibodies have been developed and showed to be more accurate and reliable than those using polyclonal antibodies. A meta-analysis also showed that the specificity of stool antigen tests based on monoclonal antibodies was 97%. European and Japanese guidelines have indicated stool antigen tests using monoclonal antibodies to be useful for primary diagnosis and assessment of eradication therapy (
4).
The worldwide prevalence of
H. pylori infection varies according to socioeconomic factors and levels of hygiene. According to a meta-analysis of 184 studies conducted from 1970 to 2016 to find out
H. pylori infection in 62 countries at different time frames, it was concluded that more than half of the world’s population were infected with
H. pylori. Whereas the U.S. and Australia have a low prevalence of
H. pylori, their indigenous populations have a high prevalence. The regions with the highest prevalence were Africa, Nigeria, Portugal, Estonia, South America, and Western Asia, while those with the lowest prevalence were Switzerland, Denmark, New Zealand, Oceana, Western Europe, and North America.
Helicobacter pylori was estimated to infect 4.4 billion people in 2015 (
5). The
H. pylori prevalence in Pakistan is at an alarming level. According to a study, 85% of chronic gastritis patients and about 100% of duodenal ulcer and duodenitis patients show evidence of infection with
H. pylori. Most of the patients were male and relatively young (
6). Another study showed a prevalence of 74.4%, with 73.5% in males and 75.4% in females. The infection increased with age, and adults were mostly affected (
7).